title: [Endocrinometabolic disorders in chronic obstructive pulmonary disease].
abstract: BACKGROUND
  Chronic obstructive pulmonary disease (COPD) is characterized by the presence of chronic airflow obstruction and associated endocrinometabolic disorders, which usually worsen the clinic and prognostic of the patients. Therefore, in-depth knowledge of these prevalent disorders in patients with COPD is relevant to develop preventive measures and early detection.
  
  
  OBJECTIVE
  To analyze the prevalence of endocrinometabolic diseases that occur in COPD subjects and their related risk factors.
  
  
  METHODS
  We carried out a bibliographic search of the bibliographic resources of the last 10 years, including PubMed, Scopus and ScienceDirect databases. Words used were: "endocrine metabolic disorders AND COPD", "endocrine disorders AND COPD" and "metabolic disorders AND COPD". The bibliographical analysis was made in two steps. During the first phase, we excluded those articles in which the title or their content did not correspond with the objective settled; during the second phase, we deleted all the references duplicated in both databases. Finally, 17 articles after full-text critical appraisal were maintained.
  
  
  RESULTS
  After reviewing the articles, we found a significant relationship between diabetes mellitus, metabolic syndrome, obesity, osteoporosis, hypogonadism and COPD. Different authors have reported a higher prevalence of these comorbidities, influencing the development of COPD.
  
  
  CONCLUSIONS
  Due to the high prevalence and association with COPD, these comorbidities have to be considered by the health professionals related to the COPD patients. Better understanding of the endocrinometabolic disorders related to COPD can influence the treatment and the outcome of patients.
authors.affiliation: Departamento de Fisioterapia, Facultad de Ciencias de la Salud, Universidad de Granada, Granada, España.
authors.forename: Irene
authors.initials: I
authors.lastname: Torres-Sánchez
authors.forename: Marie Carmen
authors.initials: MC
authors.lastname: Valenza
authors.forename: Fernando
authors.initials: F
authors.lastname: Carrasco
authors.forename: Irene
authors.initials: I
authors.lastname: Cabrera-Martos
authors.forename: Gerald
authors.initials: G
authors.lastname: Valenza-Demet
authors.forename: Marcelo
authors.initials: M
authors.lastname: Cano-Capellaci
mesh_terms: D015897:Comorbidity; D004700:Endocrine System Diseases / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008659:Metabolic Diseases / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000453:epidemiology; D012307:Risk Factors